Politics Pfizer and BioNTech Begin Phase 1 Study of Combined mRNA-Based Vaccine for COVID-19 and Influenza By faturananet - 3 de novembro de 2022 0 109 Facebook Twitter Google+ Pinterest WhatsApp Here We Go: Pfizer and BioNTech Begin Phase 1 Study of Combined mRNA-Based Vaccine for COVID-19 and Influenza Tap here to add The Western Journal to your home screen. Source link
